Article info
PDFOriginal article
New direct-acting antivirals for hepatitis C treatment and neuropsychiatric symptoms in psychiatric risk groups
- Correspondence to Miss Marta Miarons, Department of Pharmacy, Mataró Hospital, Mataró, Spain; mmiarons{at}csdm.cat
Citation
New direct-acting antivirals for hepatitis C treatment and neuropsychiatric symptoms in psychiatric risk groups
Publication history
- Received July 12, 2017
- Revised January 8, 2018
- Accepted January 9, 2018
- First published January 27, 2018.
Online issue publication
May 01, 2020
Article Versions
- Previous version (7 May 2019).
- Previous version (7 May 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists (unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.